



Distinctive patterns of placental lesions in preeclampsia versus fetal growth 
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What does this work add to what is already known?   
Our study provides a comprehensive description of the placental lesions according to a 
systematic classification in the different clinical PE and/or FGR phenotypes, 
establishing also the association with fetoplacental Doppler. 
What are the clinical implications of this work?  
The placenta is an essential organ for the understanding of most relevant obstetric 
complications, revealing different placental lesions associated with the corresponding 

















Objectives: The aim of this study was to describe placental histopathological findings 
in a large cohort of pregnancies complicated by preeclampsia and/or fetal growth 
restriction, and to investigate its association with fetoplacental Doppler. 
Methods: This was a prospective observational study including pregnancies 
complicated by: 1) normotensive FGR defined as birthweight <10
th
 centile (n=184); 2) 
PE with normally growth fetuses (n=102); 3) PE&FGR (n=120); and 4) uncomplicated 
pregnancies (n=202). Uterine, umbilical and middle cerebral artery pulsatility indeces 
(PI) were assessed. Cerebroplacental ratio (CPR) was calculated by dividing the middle 
cerebral artery PI by the umbilical artery PI. Abnormal parameters were considered 
when PI >95
th
 centile for uterine and umbilical artery, or <5
th
 centile for middle cerebral 
artery and CPR. Placental lesions were categorized to vascular (maternal/fetal side), 
inflammatory and other lesions according to the 2014 Amsterdam Placental Workshop 
Group Consensus Statement. Univariate and multiple regression analysis were 
performed for the comparison between the study groups. Logistic regression was used 
to determine abnormal Doppler association with placental lesions. 
Results: Maternal side vascular lesions are significantly higher in PE compared to 
controls and normotensive FGR (PE&FGR: 73%, PE: 46%, FGR: 38% vs. controls: 
31%; p=0.01) including 2 types of lesions: developmental (PE&FGR: 13%, PE: 5%, 
FGR: 3% vs. controls: 2%, p<0.001) and malperfusion (PE&FGR: 70%, PE: 39%, 
FGR: 32% vs. controls: 25%, p=0.001). In contrast, fetal side developmental lesions are 
significantly higher in normotensive FGR compared to controls and PE (PE&FGR: 0%, 
PE: 3%, FGR: 8% vs. controls 2%, p=0.001). All cases displayed lower prevalence of 














17.5%, PE: 7.8%, FGR: 9.8% vs. controls 9.4%, p=0.001). All fetoplacental Doppler 
parameters are associated with maternal side vascular lesions -mainly malperfusion- 
[uterine arteries mean PI (Odds ratio(OR)=2.45, 95% confidence interval (CI): 1.51 – 
3.97), umbilical artery PI (OR=2.05, 95% CI: 1.02 – 4.47), middle cerebral artery PI 
(OR=2.75, 95% CI: 1.4 – 5.42), CPR (OR=1.75, 95% CI: 1.04 – 2.95)]. This association 
was evident mainly in the FGR groups -with and without PE-, being nonsignificant in 
controls or PE without FGR. No significant associations were observed between 
fetoplacental Doppler parameters and other placental lesions in any of the study groups.  
Conclusions: PE and FGR exhibit different patterns of placental histopathological 
lesions in accordance with the clinical manifestation of the placental disorder (maternal 
vs. fetal). Fetoplacental Doppler shows an association with placental malperfusion 


















 Preeclampsia (PE) and fetal growth restriction (FGR) are considered "great 
obstetrical syndromes" being responsible for short and long-term detrimental health 
consequences for both the mother and the fetus.
1
 PE is a multisystem disorder that 
affects 2-5% of pregnancies
2
 and is a leading cause of maternal and perinatal morbidity 
and mortality.
3,4
 FGR, defined as the failure to achieve the endorsed fetal growth 
potential, affects 7-10% of all pregnancies
5
 and is associated with poor perinatal 
outcomes
6,7
 and long-term health consequences.
8,9
  
 Placental insufficiency is the most commonly accepted mechanism in both PE 
and FGR.
10
 However, the diverse clinical phenotypes of these two conditions may 
exhibit different patterns of placental lesions.
11,12
 Clinical and experimental evidence 
suggest that abnormal trophoblast invasion with a failure of physiological 
transformation of the spiral arteries is responsible for placental maldevelopment and 
impaired perfusion, which subsequently leads to placental insufficiency.
13–15
 However, 
the differential pathways that lead to a systemic maternal disease (PE) or to a restrained 
condition compromising the transfer of nutrients and oxygen to the fetus (FGR), have 
not been elucidated. Pathological evaluation of the placenta could be particularly 
relevant to reveal the differences of these two conditions; however, it‘s limited by the 
heterogeneity in the taxonomy of placental lesions.
 
In 2014, the Amsterdam Placental 
Workshop Group Consensus Statement recommended a standardized approach to 
describe histopathological placental findings,
16
 which was endorsed by several authors
17
 
and intended to reduce the variability in placental examinations. Although many studies 




, none of them 














Fetoplacental Doppler is used widely in the clinical monitoring of PE and FGR, but still 
there is a gap of knowledge regarding what type of placental lesions is associated with 
abnormal Doppler. The aim of this study was to characterize placental histopathological 
lesions using this new classification in a large prospective cohort of pregnancies 
complicated by PE and/or FGR. As a secondary objective, we planned to investigate the 

















This was a prospective observational study including all singleton gestations 
with a diagnosis of PE and/or FGR that attended at the Departments of Maternal-Fetal 
Medicine at BCNatal (Barcelona, Spain) between January 2014 and June 2017. FGR 
was defined as a birthweight below the 10
th
 centile according to local standards 





 centile) and those considered as growth restricted (with a birthweight <3
rd
 
centile and/or abnormal mean uterine arteries (UtA) pulsatility index (PI) and/or 
abnormal cerebroplacental ratio (CPR)).
37
 PE was defined as high blood pressure 
(systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg on two 
occasions, at least four hours apart), developed after 20 weeks of gestation, with 
proteinuria (≥300 mg/24 hours).
2,38
 Controls were randomly selected from 
uncomplicated low-risk pregnancies with normotensive mothers and an appropriate for 
gestational age fetus (confirmed birthweight above 10
th
 centile). Spontaneous preterm 
deliveries without clinical signs of infection, or iatrogenic preterm deliveries due to 
placenta previa were recruited as preterm controls. Preterm deliveries were considered 
when gestational age at delivery was ≥24 and <37 weeks gestation including both early 
and late preterm deliveries. Term deliveries included pregnancies with gestational age at 
delivery ≥37 and <42 weeks of gestation. Pregnancies with chromosomal or structural 
anomalies or suspected intrauterine infection were excluded. The hospital ethics 
committee approved the study protocol, and all patients gave written informed consent 















 The following data were recorded upon enrollment: maternal age, ethnicity, 
body mass index (BMI), parity, smoking status, known chronic disease (i.e., 
hypertension, diabetes mellitus) and obstetric history. Gestational age was established 
by crown-rump length at first trimester.
39
 Fetoplacental Doppler was obtained in the last 
2 weeks of pregnancy and included: umbilical artery (UA) PI, calculated from three or 
more consecutive waveforms obtained from a free-floating portion of the umbilical cord 
at insonation angles of less than 30°; middle cerebral artery (MCA) PI at the proximal 
portion of the vessel; CPR, calculated as the ratio of MCA-PI to UA-PI;
40
  and UtA-PI, 
calculated as the average PI of the right and left arteries.
41
 At delivery, spontaneous 
onset of labor, route of delivery, gestational age, birth weight, birth weight centile, 
Apgar score, umbilical artery pH and placental pathology data were collected. 
Follow up and management 
All pregnancies with FGR diagnosis were monitored fortnightly with fetal 
growth evaluation, amniotic fluid assessment and Doppler measurements. The 
management of these pregnancies relied on a standardized protocol.
5
 Indications for 
labor induction were as follows:  1) at ≥26 weeks‘ gestation: non-reassuring 
cardiotocography register and/or reversed ductus venosus (DV) diastolic flow 2) at ≥30 
weeks‘ gestation, one or more of the following: UA reversed end diastolic volume, DV-
PI ≥95
th
 centile, DV absent diastolic flow 3) at ≥34 weeks‘ gestation: UA absent end 
diastolic volume 4) at ≥37 weeks‘ gestation, one or more of the following: estimated 
fetal weight <3
rd
 centile, persistent (12 h apart) MCA-PI <5
th
 centile or UA-PI > 95
th
 
centile or CPR <5
th
 centile, UtA-PI >95
th



















scenarios, termination of pregnancy was by cesarean section, whereas in the next 2 by 
labor induction. 
Pregnancies diagnosed with PE were classified as mild (to be terminated at ≥37 
weeks) and severe (to be terminated at ≥34 weeks or before if applies). Severe PE was 
considered when it presented with one or more of the following
38
: blood pressure ≥160 
mmHg systolic or ≥110 mmHg diastolic on two occasions at least 4 hours apart, 
thrombocytopenia (<100000/mm
3
), impaired liver function (elevated blood 
concentrations of liver enzymes to twice normal concentration and/or severe persistent 
right upper quadrant or epigastric pain unresponsive to medication and not accounted 
for by alternative diagnoses), progressive renal insufficiency (serum creatinine 
concentration >1.1 mg/dl), pulmonary edema, new-onset cerebral or visual 
disturbances. Pregnancy termination was by labor induction or cesarean section upon 
obstetric indication. 
Labor induction was achieved by hormonal cervical ripening with a slow-release 
prostaglandin E2 vaginal pessary (10mg) or mechanical with foley catheter. Oxytocin 
induction was indicated thereafter for failure of labor onset within 18 h. During the 
labor course, cesarean or operative vaginal delivery was indicated for non-reassuring 
fetal status, based on abnormal fetal heart rate tracing
42
 and adverse fetal scalp blood pH 
during intrapartum monitoring. 
Placental evaluation  
 Placental examinations adhered to a standard laboratory protocol.
16
 Placentas 
were fixed in 10% buffered formalin. Trimmed placentas were weighted (after removal 
of the membranes, cord and any blood clots) and weight centiles were assigned based 
on gestational age-specific placenta weight charts.
43














were taken for routine processing: three blocks containing a full thickness of normal-
appearing placental parenchyma, two cross sections of umbilical cord, one rolled strip 
of membranes and samples from all visible lesions. Final slides were stained using 
hematoxylin and eosin. Diagnostics from pathology reports were classified according to 
Redline‘s classification following the 2014 Amsterdam Placental Workshop Group 
Consensus Statement.
16
 Placental lesions were classified as vascular (maternal/fetal 
side), inflammatory-immune and other lesions.
17
 Maternal and fetal vascular-stromal 
findings were classified as developmental, malperfusion or loss of integrity lesions. 
Inflammatory-immune processes included infectious (acute/chronic) and 
immune/idiopathic lesions. Other placental histopathological lesions were recorded 
separately.  
To address reproducibility, a sample of 40 placentas (10 from each group) was 
selected randomly for re-evaluation, and pathologists were blinded to group 
classification and previous histologic diagnosis. An overall agreement of 87.5% was 
obtained by comparing the conventional placental pathology reports and the 40 
placentas selected to assess reproducibility. 
Statistical analysis 
Data are presented as continuous or categorical variables. Differences in 
continuous and categorical variables were evaluated by Mann Whitney U, Pearson χ² or 
Fisher‘s exact test as appropriate. Multiple regression analysis was performed, and 
results were adjusted for confounding factors, including maternal race, pre-gestational 
BMI, smoking, nulliparity, gestational age at delivery, route of delivery and 














gestational age at delivery term vs preterm was additionally performed (supplementary 
material). Probability values p<0.05 were considered statistically significant. 
To investigate fetoplacental Doppler association with placental lesions, 
abnormal Doppler parameters were dichotomized into normal or abnormal when PI 
>95
th
 centile for UtA and UA, or <5
th
 centile for MCA and CPR. Logistic regression 
was used to calculate the adjusted odds ratios indicating the presence of placental 
lesions in the case of abnormal Doppler including all the pregnancies from the whole 
population. This analysis was performed also in the different groups of the study. Odds 
ratios were adjusted for maternal race, pre-gestational BMI, smoking, nulliparity, 
gestational age at delivery, route of delivery and spontaneous onset of labor. All 
















A total of 608 pregnancies were included. Baseline characteristics, fetoplacental 
Doppler, and perinatal outcomes are shown in Table 1. Nulliparity and tobacco 
consumption were significantly higher in normotensive FGR pregnancies with a 
significantly lower maternal BMI. In contrast, preeclamptic patients with and without 
FGR had higher pre-gestational BMI and chronic comorbidities. With regards to the 
fetoplacental Doppler, UtA PI was significantly higher in all groups compared to 
controls, and the highest values were present in PE&FGR (Table 1). Additionally, the 
CPR z-score was significantly lower in groups with growth-restricted fetuses (with or 
without PE) compared to controls, especially in PE&FGR. As expected, all groups had 
an earlier gestational age at delivery compared to controls, less frequent spontaneous 
onset of labor and significantly increased prevalence of cesarean sections in pregnancies 
complicated by PE. 
Placental evaluation and histopathological findings  
Placental weight and diameters were significantly lower in pregnancies with FGR 
compared to the other groups. Table 2 shows the morphological characteristics and 
histopathological lesions of the placenta and Figure 1 reveals the cumulative percentage 
of placental lesions observed among the different study groups. In normotensive FGR, 
vascular developmental lesions in the fetal side (chorangiosis mainly) were significantly 
higher in comparison to other groups. In both PE groups (with or without FGR), fetal 
side vascular lesions were less frequent compared to other groups. In addition, 
PE&FGR exhibited an increase of maternal side vascular lesions including 2 types, 














with normally grown fetuses presented a nonsignificant increase of malperfusion 
lesions. Moreover, immune lesions (chronic villitis principally) were more prevalent in 
PE&FGR. Other immune lesions i.e. chronic histiocytic intervillositis presented with a 
low prevalence in the study cohort, it was observed in 1% of uncomplicated 
pregnancies, 1.1% of normotensive FGR and none of PE pregnancies. Infectious lesions 
were less frequent in all groups compared to controls particularly in PE&FGR.  
A subanalysis according to gestational age at delivery showed similar patterns of 
placental lesions in association with PE and/or FGR, mainly in the preterm 
subpopulation (see supplemental material for details). Preterm cases of normotensive 
FGR were associated with maternal side malperfusion lesions (Table S2). 
Association of fetoplacental Doppler with placental findings  
As seen in Figure 2, all fetoplacental Doppler parameters (UtA, UA, MCA PI and CPR) 
were associated with maternal side vascular lesions without any significant association 
with fetal side vascular, inflammatory or other placental lesions. Actually, all 
pregnancies with fetal side developmental lesions in the placenta presented 
fetoplacental Doppler results within the normal ranges. Table 3 show adjusted odds 
ratios of each study group. Association with placental maternal side vascular lesions 
was mainly evident in normotensive FGR group with UtA or UA PI >95
th
 centile and in 

















The present study describes diverse patterns of placental lesions in a large well-
characterized cohort displaying different clinical phenotypes of PE and FGR. Our data 
suggest that maternal PE is mainly associated with maternal side lesions, while FGR is 
associated with fetal side findings. Increased prevalence of immune processes was 
observed when both PE and FGR co-occur in the same pregnancy. In addition, we could 
demonstrate a significant association between placental maternal vascular lesions and 
fetoplacental Doppler, particularly in FGR complicated pregnancies.  
Placentas from normotensive FGR pregnancies were significantly smaller and 
presented higher prevalence of fetal side developmental lesions where chorangiosis was 
the main finding. Chorangiosis, defined as extreme villous hypervascularity, was 
proposed to be a protective mechanism of the placenta against in utero hypoxia.
44
 
Despite being able to describe ‗typical‘ vascular lesions in some cases of normotensive 
FGR (about 8-10%), a large proportion of cases displayed a placenta similar to controls. 
Previous studies described a variety of histopathological findings in FGR, ranging from 
morphologically unremarkable to delayed villous maturation
45
, pronounced maternal 
malperfusion lesions
46
 or fetal villous changes.
47 
This variability could be explained by 
the different phenotypes included in each study. Placental growth factor assessment in 
maternal plasma could help in detecting ―placental‖ FGR.
48
 In this study, we show that 
preterm FGR cases are associated with maternal side malperfusion lesions, whereas 
term cases showed the same prevalence as controls.  
Pregnancies complicated by PE and FGR exhibited higher prevalence of 














maternal malperfusion has been well-established
15
 and correlated with the severity of 
PE.
21,26,27,49
 Developmental lesions were also increased in PE&FGR. Our data suggest 
that decidual arteriopathy (the most common developmental finding) could represent a 
key insult in this subgroup of PE, causing maternal malperfusion that mediates utero-
placental ischemia.
50
 However, malperfusion could also be originated from placental 
hypoperfusion due to maternal hemodynamic maladaptation which is most probably the 
mechanism underlying placental involvement in PE without FGR.
51
 In addition, 
immune lesions were significantly higher in PE&FGR, mostly chronic villitis which has 




In addition, we observed a lower prevalence of infectious lesions in the cases 
groups, likely related to the lower rate of spontaneous onset of labor, as most PE and/or 
FGR pregnancies went through medically indicated delivery. Moreover, we noticed a 
high prevalence of vascular or inflammatory lesions in uncomplicated pregnancies 
which is consistent with the results of a recent study by Romero et al. demonstrating the 




 We also provide evidence of an association between placental lesions and feto-
placental Doppler. All the evaluated parameters (UtA, UA, MCA PI and CPR) showed 
a significant association with maternal side vascular findings. It has been previously 
proposed that abnormal Doppler parameters reflect the degree of placental insufficiency 
and are associated with placental findings indicative of placental underperfusion 
(without distinguishing maternal from fetal side lesions).
54


















 or both arteries 
PI.
57
 In addition, abnormal CPR was associated with mural hypertrophy and maternal 
vascular underperfusion in FGR.
58
 However, abnormal Doppler flow cannot be solely 
explained by altered uteroplacental histopathology.
59–61
 On the other hand, FGR cases 
with normal fetoplacental Doppler exhibited higher prevalence of placental findings 
compared to uncomplicated pregnancies.
35
 Additionally, UtA PI showed the ability to 
predict villous infarcts in PE.
62
 Overall, fetoplacental Doppler seem to reflect placental 
vascular findings related to malperfusion. In the present study, with the use of a 
systematic classification for placental findings we demonstrate that abnormal 
fetoplacental Doppler is associated with maternal side vascular lesions and not with the 
fetal side or any other lesions. 
Our study shows both strengths and limitations that worth mentioning. One of the 
strengths is the prospective design including well-characterized clinical phenotypes of 
PE and/or FGR, as well as uncomplicated pregnancies. Moreover, we used the most 
recent and comprehensive classification of placental findings
17
 in accordance with the 
2014 Amsterdam Placental Workshop Group criteria
16
, which established an agreed-
upon protocol for sampling the placenta, and diagnostic criteria for placental lesions. As 
limitations, we acknowledge that pathologists were not completely blinded to the main 
diagnosis. Additionally, we have not considered any grading or staging of the lesions in 
our analysis, as our goal was focused on revealing the different placental patterns upon 
the presence/absence of specific placental findings. With regards to fetoplacental 
Doppler, we acknowledge the limited number of pregnancies with abnormal UA or 














restrained the calculation of correspondent odds ratio. Furthermore, the analysis of 
angiogenic factors profile in these patients could be of interest in future research. 
 The placenta is an essential organ for understanding the most relevant obstetric 
complications. In conclusion, different placental histopathological lesions are associated 
with their corresponding clinical presentations, as placental maternal side lesions are 
mainly associated with maternal disease -PE-, whereas fetal side lesions are mainly 
involved in the fetal phenotype -FGR-. Fetoplacental Doppler parameters (UtA, UA, 
MCA PI and CPR) seem to be associated with placental maternal side lesions 
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Figure 1. Distribution of placental histopathological lesions among the study groups. 
Columns show cumulative percentage of placental lesions. FGR, fetal growth 





Figure 2. Fetoplacental Doppler association with placental histopathological lesions. 
Bars demonstrate adjusted odds ratio with 95% confidence interval. UtA, uterine 
arteries; UA, umbilical artery; MCA, middle cerebral artery; CPR, cerebroplacental 
ratio. Odds ratios were adjusted for maternal race, pre-gestational BMI, smoking, 













































    
Age (years) 
33.6 
(30.5 – 36.5) 
33.4 
(29 – 36.4) 
34.4 
(31.4 – 37.1)† 
35 
(30.1 – 37.8)† 





(20.5 – 25.3) 
21.6 
(19.8 – 23.4)* 
25.8 




Race     
  White 131 (65.2) 140 (76.5) 50 (49)† 73 (60.8) 
  Latin-American 30 (14.9) 13 (7.1) 24 (23.5)*† 17 (14.2)∫ 
  South Asian 24 (11.9) 23 (12.6) 20 (19.6)* 11 (9.2)∫ 
  African 2 (1) 2 (1.1) 5 (4.9) 9 (7.5)*† 
  Others 14 (7) 5 (2.7) 3 (2.9) 10 (8.3) 
Nulliparity 93 (46) 109 (60.6)* 55 (53.9) 81 (67.5)*∫ 
Smoking during 
pregnancy 
23 (11.4) 48 (26.8)* 10 (9.8)† 19 (15.8)† 
Chronic hypertension 4 (2) 4 (2.2) 19 (18.6)*† 14 (11.7)*† 
Pre-gestational 
diabetes 
2 (1) 5 (2.7) 17 (16.7)*† 4 (3.3)∫ 
















(-1.1 – 0.79) 
0.54 
(-0.34 – 2)* 
0.52 
(-0.63 – 1.97)* 
2.81 
(1.92 – 3.5)*†∫ 
UA- PI (z-score) 
-0.22 
(-0.6 – 0.21) 
0.32 





(0.14 – 1.9)*†∫ 
MCA-PI (z-score) 
0.01 
(-0.68 – 0.74) 
-0.26 
(-0.96 – 0.47)* 
-0.32 
















Perinatal outcomes     
Spontaneous onset of 
labor 
106 (52.5) 34 (18.5)* 7 (6.9)*† 7 (5.8)* 
Cesarean section 67 (33.7) 84 (46.4) 70 (68.6)*† 84 (70.6)*† 
Gestational age at 
delivery (weeks) 
39 
(35.7 – 40.1) 
37.7 
(37 – 39.4)* 
37.1 






(2510 – 3420) 
2337 
(1935 – 2613)* 
2737 




Birth weight centile 
38 
(22 – 64) 
1.5 
(0 – 4.5)* 
38 
(17 – 83)† 
0 
(0 – 1)*∫ 















Data are median (interquartile range) or n (percentage).  
AGA, appropriate for gestational age; FGR, fetal growth restriction; UtA, uterine arteries; UA, umbilical artery; 
MCA, middle cerebral artery; PI, pulsatility index; CPR, cerebroplacental ratio. ¥ Fetal acidosis was 
defined as umbilical arterial cord blood pH <7.1. 
* p<0.05 by Manne Whitney U, Pearson χ², or Fisher‘s exact tests as appropriate, compared to controls. 
† p<0.05 by Manne Whitney U, Pearson χ², or Fisher‘s exact tests as appropriate, compared to normotensive FGR. 
∫ p<0.05 by Manne Whitney U, Pearson χ², or Fisher‘s exact tests as appropriate, compared to preeclampsia + 
AGA. 
APGAR 5 min <7 3 (1.5) 7 (3.8) 3 (2.9) 11 (9.3)*† 















Table 2. Placental morphological characteristics and histopathological lesions among 















    
Placental weight (g)  479  
(402 – 540) 
357  
(292 – 425)* 
489 
(375 – 565)† 
290 
(220 – 358)*†∫ 
Placental weight <10th 
centile  
18 (9) 72 (39.1)* 4 (4)† 37 (31.1)*∫ 
Placental weight <3rd 
centile 
6 (3) 32 (17.4)* 0 (0)† 10 (8.4)*∫ 
Placental length (cm)  17  
(15.5 – 18.8) 
15.5  
(14 – 17)* 
17  
(16 – 18)† 
14  
(12 – 15)*†∫ 
Placental breadth (cm)  15.5  
(14 – 17) 
14  
(12 – 15.3)* 
15 
(14 – 16.5)† 
11.8  
(10 – 13.5)*†∫ 
Placental thickness (cm)  2.5  
(2 – 3) 
2  
(1.5 – 2.5)* 
2.5  
(2 – 3)† 
2.2  
(2 – 3) 
Histopathological 
lesions 
    
1.Vascular lesions  
    
Maternal side lesions 
62 (30.7) 70 (38) 47 (46.1) 88 (73.3)*†∫ 
   maldevelopment  
3 (1.5) 5 (2.7) 5 (4.9) 16 (13.3)*†∫ 
   malperfusion  
51 (25.2) 58 (31.5) 40 (39.2) 84 (70)*†∫ 
   loss of integrity  
15 (7.4) 15 (8.2) 6 (5.9) 11 (9.2) 
Fetal side lesions 
57 (28.2) 57 (31) 23 (22.6)* 27 (22.5)*† 
   maldevelopment  
4 (2) 15 (8.2)* 3 (2.9) 0 (0)† 
   malperfusion  














   loss of integrity  
37 (18.3) 28 (15.2) 19 (18.6) 14 (11.7)* 
Combined maternal and 
fetal side lesions 
22 (11) 23 (12.6) 15 (14.7) 20 (16.7) 
   maldevelopment 
0 (0) 0 (0) 0 (0) 0 (0) 
   malperfusion 
7 (3.5) 10 (5.5) 3 (2.9) 8 (6.7) 
   loss of integrity 
3 (1.5) 1 (0.6) 0 (0) 1 (0.8) 
2.Inflammatory lesions 
    
Infectious lesions 
35 (17.3) 17 (9.2)† 7 (6.9)† 5 (4.2)* 
Immune lesions  
19 (9.4) 18 (9.8) 8 (7.8) 21 (17.5)*†∫ 
3.Other lesions 





5 (2.5) 7 (3.8) 1 (1) 2 (1.7) 
Data are median (interquartile range) or n (percentage).  
AGA, appropriate for gestational age; FGR, fetal growth restriction. 
* p<0.05 by linear or logistic regression as appropriate, compared to controls. 
† p<0.05 by linear or logistic regression as appropriate, compared to normotensive 
FGR. 
∫ p<0.05 by linear or logistic regression as appropriate, compared to preeclampsia + 
AGA. 
Results were adjusted for maternal race, pre-gestational BMI, smoking, nulliparity, 














Combined maternal and fetal side lesions were considered when lesions in both sides 

















Table 3. Fetoplacental Doppler association with maternal side vascular lesions in the 


















(0.43 – 6.03) 
3.14 
(1.36 – 7.24)* 
5.51 
(0.72 – 41.91) 
1.84 
(0.63 – 5.38) 






(1.01 – 14.15)* 
NA 
1.18 







(0.57 – 6.24) 
2.39 
(0.19 – 30) 
1.5  
(0.48 – 4.66) 
CPR <5
th
 centile  
5.99 
(1.04 – 34.62)* 
1.91  
(0.79 – 4.62) 
9.12 
(0.87 – 96.03) 
0.91 
(0.34 – 2.46) 
Data are adjusted odds ratio (95% confidence interval).  
AGA, appropriate for gestational age; FGR, fetal growth restriction; NA: nonapplicable. 
* p<0.05 by logistic regression. Odds ratios were adjusted for maternal race, pre-
gestational BMI, smoking, nulliparity, gestational age at delivery, route of delivery and 
spontaneous onset of labor. 
When there were very few cases having abnormal fetoplacental Doppler the calculation 
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